Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
暂无分享,去创建一个
R. Schnabel | P. Ellinor | T. Zeller | K. Wegscheider | S. Kany | C. Roselli | J. Pirruccello | L. Fabritz | Linda Krause | K. Borof | A. Suling | B. Reissmann | P. Kirchhof | A. Zapf | C. Al-Taie | Carla Reinbold | Bruno Reissmann | Larissa Fabritz
[1] H. Crijns,et al. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial , 2022, European heart journal.
[2] Marc P. Bonaca,et al. A polygenic risk score predicts atrial fibrillation in cardiovascular disease. , 2022, European heart journal.
[3] G. Breithardt,et al. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden , 2022, Circulation.
[4] E. Ashley,et al. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2022, Circulation.
[5] John A. Williams,et al. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank , 2022, Heart.
[6] G. Breithardt,et al. Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy. , 2022, Journal of the American College of Cardiology.
[7] A. Philippakis,et al. The potential of polygenic scores to improve cost and efficiency of clinical trials , 2022, Nature Communications.
[8] D. Fatkin,et al. Polygenic Risk Scores Identify Atrial Electrophysiological Substrate Abnormalities and Predict Atrial Fibrillation Recurrence Following Catheter Ablation , 2022, Heart, Lung and Circulation.
[9] L. Gailīte,et al. A Higher Polygenic Risk Score Is Associated with a Higher Recurrence Rate of Atrial Fibrillation in Direct Current Cardioversion-Treated Patients , 2021, Medicina.
[10] H. Crijns,et al. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] G. Breithardt,et al. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial , 2021, European heart journal.
[12] G. Breithardt,et al. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure , 2021, Circulation.
[13] P. Kirchhof,et al. Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how? , 2021, Cardiovascular research.
[14] Brian E. Cade,et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.
[15] Deepak L. Bhatt,et al. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease. , 2020, Circulation.
[16] G. Breithardt,et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.
[17] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[18] M. Rivas,et al. Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals With Atrial Fibrillation , 2020, medRxiv.
[19] Jay A. Montgomery,et al. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation , 2020, Circulation. Arrhythmia and electrophysiology.
[20] Spiros C. Denaxas,et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure , 2020, Nature Communications.
[21] P. Ellinor,et al. Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score , 2019, Circulation.
[22] A. Philippakis,et al. The "All of Us" Research Program. , 2019, The New England journal of medicine.
[23] G. Hindricks,et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.
[24] Cathie Sudlow,et al. UK Biobank: opportunities for cardiovascular research , 2017, European heart journal.
[25] P. Donnelly,et al. The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.
[26] Mary E. Haas,et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.
[27] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.
[28] K. Lunetta,et al. Heritability of Atrial Fibrillation , 2017, Circulation. Cardiovascular genetics.
[29] G. Hindricks,et al. Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation , 2017, PloS one.
[30] Dermot F. Reilly,et al. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting , 2017, Circulation.
[31] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[32] Jay A. Montgomery,et al. Common Genetic Variants and Response to Atrial Fibrillation Ablation , 2015, Circulation. Arrhythmia and electrophysiology.
[33] D. Roden,et al. Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. , 2012, Journal of the American College of Cardiology.
[34] G. Hindricks,et al. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. , 2010, Journal of the American College of Cardiology.
[35] Jesper Hastrup Svendsen,et al. Familial Aggregation of Atrial Fibrillation: A Study in Danish Twins , 2009, Circulation. Arrhythmia and electrophysiology.
[36] A. Figueiras,et al. Regression models: calculating the confidence interval of effects in the presence of interactions. , 1998, Statistics in medicine.
[37] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.